Jakub Mesinovic, Jackson J. Fyfe, Jason Talevski, Michael J. Wheeler, Gloria K.W. Leung, Elena S. George, Melkamu T. Hunegnaw, Costas Glavas, Paul Jansons, Robin M. Daly, David Scott
Diabetes Metab J. 2023;47(6):719-742. Published online September 14, 2023
Type 2 diabetes mellitus (T2DM) and sarcopenia (low skeletal muscle mass and function) share a bidirectional relationship. The prevalence of these diseases increases with age and they share common risk factors. Skeletal muscle fat infiltration, commonly referred to as myosteatosis, may be a major contributor to both T2DM and sarcopenia in older adults via independent effects on insulin resistance and muscle health. Many strategies to manage T2DM result in energy restriction and subsequent weight loss, and this can lead to significant declines in muscle mass in the absence of resistance exercise, which is also a first-line treatment for sarcopenia. In this review, we highlight recent evidence on established treatments and emerging therapies targeting weight loss and muscle mass and function improvements in older adults with, or at risk of, T2DM and/or sarcopenia. This includes dietary, physical activity and exercise interventions, new generation incretin-based agonists and myostatin-based antagonists, and endoscopic bariatric therapies. We also highlight how digital health technologies and health literacy interventions can increase uptake of, and adherence to, established and emerging treatments and therapies in older adults with T2DM and/or sarcopenia.
Citations
Citations to this article as recorded by
Higher body mass index increases the risk of shoulder adhesive capsulitis in young adults: a nationwide cohort study Jong-Ho Kim, Jae-Yoon Baek, Kyung-Do Han, Bong-Seoung Kim, Hyuk-Sang Kwon Journal of Shoulder and Elbow Surgery.2025; 34(1): 26. CrossRef
Unraveling the dual threat: sarcopenia and insufficient physical activity in diabetes risk Hui Shi Frontiers in Endocrinology.2025;[Epub] CrossRef
Molecular insights into Parkinson's disease and type 2 diabetes mellitus: Metformin's role and genetic pathways explored Tingting Liu, Haojie Wu, Jianshe Wei Experimental Neurology.2025; 385: 115137. CrossRef
Evaluation of the effect of testosterone replacement therapy with a transdermal testosterone on glycemic control in men with type 2 diabetes mellitus R. V. Rozhivanov, M. O. Chernova, V. A. Ioutsi, G. A. Mel’nichenko, M. V. Shestakova, E. R. Rozhivanova, E. N. Andreeva, N. G. Mokrysheva Diabetes mellitus.2024; 27(2): 120. CrossRef
Higher dietary live microbe intake is associated with a lower risk of sarcopenia Kemin Yan, Xiaoyi Ma, Chen Li, Xiang Zhang, Manxuan Shen, Sai Chen, Jia Zhao, Wen He, Hua Hong, Yingying Gong, Gang Yuan Clinical Nutrition.2024; 43(7): 1675. CrossRef
d-Pinitol Improves Diabetic Sarcopenia by Regulation of the Gut Microbiome, Metabolome, and Proteome in STZ-Induced SAMP8 Mice Xin Yu, Pei Li, Baoying Li, Fei Yu, Wenqian Zhao, Xue Wang, Yajuan Wang, Haiqing Gao, Mei Cheng, Xiaoli Li Journal of Agricultural and Food Chemistry.2024; 72(25): 14466. CrossRef
Proteomics Analysis Provides Insights into the Role of Lipid Metabolism in T2DM-Related Sarcopenia Jingying Wu, Shengnan Wang, Huafeng Zhuang, Weichun Wang, Yaoguo Wang, Youfang Chen, Zhengping Huang, Chunnuan Chen, Xiaofeng Chen ACS Omega.2024; 9(31): 34056. CrossRef
Age- and sex-dependent associations between self-reported physical activity levels and self-reported cardiovascular risk factors: a population-based cross-sectional survey Johannes Burtscher, Martin Kopp, Jeannette Klimont, Hanno Ulmer, Barbara Strasser, Martin Burtscher BMC Public Health.2024;[Epub] CrossRef
Addressing broader dietary patterns and physical activity in the study of dietary live microbe intake and sarcopenia Chun-Yu Shen, Chen-Pi Li, Hui-Chin Chang, Shuo-Yan Gau Clinical Nutrition.2024; 43(10): 2388. CrossRef